TABLE 1.
Day | Virus | % IFN-γ+ CD8+ T cells (mean ± SD)
|
||||
---|---|---|---|---|---|---|
NP | PA | PB1 | NS2 | M1 | ||
0 | WT | 0.6 ± 0.1 | 0.3 ± 0.08 | 0.4 ± 0.1 | 0.07 ± 0.04 | 0.01 ± 0.02 |
−NP | 0.02 ± 0.03* | 0.24 ± 0.07 | 0.3 ± 0.15 | 0.07 ± 0.03 | 0.01 ± 0.02 | |
−PA | 1.0 ± 0.1 | 0.01 ± 0.03* | 0.15 ± 0.05 | 0.08 ± 0.05 | 0.01 ± 0.01 | |
−NP−PA | 0.04 ± 0.03* | 0.02 ± 0.03* | 0.16 ± 0.1 | 0.08 ± 0.06 | 0.02 ± 0.02 | |
7 | WT | 10.9 ± 0.4 | 1.0 ± 0.5 | 1.5 ± 0.6 | 0.5 ± 1.3 | 0.14 ± 0.07 |
−NP | 0.2 ± 0.1* | 2.7 ± 1.0 | 5.6 ± 1.8* | 1.7 ± 0.8 | 0.17 ± 0.06 | |
−PA | 13.4 ± 4.9 | 0.5 ± 0.09* | 4.3 ± 0.9* | 3.1 ± 1.3* | 0.16 ± 0.15 | |
−NP−PA | 0.2 ± 0.06* | 0.4 ± 0.3* | 3.8 ± 1.0* | 4.69 ± 1.8* | 0.48 ± 0.40 | |
10 | WT | 15.2 ± 6.1 | 1.3 ± 0.1 | 2.3 ± 1.0 | 0.9 ± 0.2 | 0.05 ± 0.02 |
−NP | 0.2 ± 0.1* | 4.1 ± 0.8* | 10.0 ± 2.9 | 4.5 ± 0.7* | 0.3 ± 0.2* | |
−PA | 13.4 ± 1.5 | 0.1 ± 0.09* | 6.2 ± 2.0 | 4.8 ± 1.0* | 0.4 ± 0.4 | |
−NP−PA | 0.03 ± 0.01* | 0.1 ± 0.1* | 3.4 ± 0.7 | 4.8 ± 1.3* | 0.3 ± 0.2 | |
30 | WT | 17.5 ± 9.0 | 2.0 ± 0.8 | 3.1 ± 1.3 | 1.7 ± 1.0 | 0.07 ± 0.05 |
−NP | 0.1 ± 0.02* | 4.9 ± 1.7* | 9.3 ± 1.5* | 3.7 ± 2.3* | 0.05 ± 0.04 | |
−PA | 14.6 ± 4.7 | 0.5 ± 0.1* | 4.1 ± 2.0 | 1.3 ± 0.9 | 0.05 ± 0.03 | |
−NP−PA | 0.1 ± 0.02* | 0.3 ± 0.1* | 4.7 ± 2.6 | 4.6 ± 1.3* | 0.2 ± 0.1 |
Ten-week-old, female B6 mice were primed i.p. with 108 EID50 of PR8 WT and mutants per mouse. The mice were challenged i.n. with homologous X31 viruses at 107 EID50 per mouse. Spleens were harvested on days 0 (8 weeks after priming), 7, 10, and 30, and the IFN-γ+ assay was performed as described in Materials and Methods. The significant differences from the WT are indicated as * (P < 0.05).